GO
Loading...

Onyx Pharma CEO's 2012 Plan

Tuesday, 10 Jan 2012 | 12:26 PM ET

Dr. Tony Coles, president & CEO of Onyx Pharmaceuticals, discusses his outlook on pharma in the new year. Biotech stocks were up 7% in 2011. "The emerging markets should be great for us," he adds.